These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25053862)

  • 1. The state of irreversible electroporation in interventional oncology.
    Silk M; Tahour D; Srimathveeravalli G; Solomon SB; Thornton RH
    Semin Intervent Radiol; 2014 Jun; 31(2):111-7. PubMed ID: 25053862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible Electroporation.
    Narayanan G
    Semin Intervent Radiol; 2015 Dec; 32(4):349-55. PubMed ID: 26622097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
    Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
    Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible Electroporation of the Pancreas.
    Chan G; Pua U
    Semin Intervent Radiol; 2019 Aug; 36(3):213-220. PubMed ID: 31435129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?
    Vroomen LGPH; Petre EN; Cornelis FH; Solomon SB; Srimathveeravalli G
    Diagn Interv Imaging; 2017 Sep; 98(9):609-617. PubMed ID: 28869200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Irreversible Electroporation in Locally Advanced Pancreatic Cancer: A Guide for the Interventional Radiologist.
    Frey GT; Padula CA; Stauffer JA; Toskich BB
    Semin Intervent Radiol; 2019 Dec; 36(5):386-391. PubMed ID: 31798212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.
    Olweny EO; Kapur P; Tan YK; Park SK; Adibi M; Cadeddu JA
    Urology; 2013 Mar; 81(3):679-84. PubMed ID: 23290141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology of irreversible electroporation and review of its clinical data on liver cancers.
    Cohen EI; Field D; Lynskey GE; Kim AY
    Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
    J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology.
    Aycock KN; Davalos RV
    Bioelectricity; 2019 Dec; 1(4):214-234. PubMed ID: 34471825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
    Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
    Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
    Dunki-Jacobs EM; Philips P; Martin RC
    Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
    Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP
    JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research Progress of Catheter-based Irreversible Electroporation for Tissue Ablation].
    Zhou Y; Han X; Ren F; Li Q; Chen X; Chu D; Wu R; Lyu Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):172-178. PubMed ID: 32400994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrolytic Effects During Tissue Ablation by Electroporation.
    Rubinsky L; Guenther E; Mikus P; Stehling M; Rubinsky B
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP95-NP103. PubMed ID: 26323571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.